ANI Pharmaceuticals | ANIP - Current Liabilities

Stock Price
80.00
Daily Change
0 0%
Monthly
1.70%
Yearly
36.54%
Q1 Forecast
79.33

ANI Pharmaceuticals reported $270.56M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AbbVie USD 39.39B 376M Sep/2025
ANI Pharmaceuticals USD 270.56M 33.72M Sep/2025
Aurora Cannabis CAD 124.12M 32.76M Sep/2025
Canopy Growth CAD 81.1M 17.56M Sep/2025
Eli Lilly USD 40.14B 1.12B Sep/2025
Hikma Pharmaceutical USD 2.06B 78M Jun/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Novartis USD 32B 286M Sep/2025
Perrigo USD 1.15B 19.2M Sep/2025
Sun Pharmaceuticals INR 234.15B 52.21B Sep/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025